Upcoming System Maintenance

Notice: Promega will be performing essential system updates January 21–25.

Order processing and shipping will pause starting January 21 at 4:00 PM CST and resume on January 26.
Please plan to order in advance for any products needed during this timeframe.

Please contact Customer Service with any questions.

HiBiT Targeted Cell Killing (TCK) Bioassays For Characterization and Potency Testing

Part # PS577

Abstract

Gopal Krishnan, Ph.D., Julia Gilden, Ph.D., Brock Binkowski, Ph.D., Nicholas J. Hess, Ph.D., Pete Stecha, M.S., Aileen Paguio, M.S., Marjeta Urh, Ph.D., Mei Cong, Ph.D.
Promega Corporation, 2800 Woods Hollow Road, Madison WI 53711

Effector cell-mediated killing of TCKCells leads to release of the HiBiT fusion protein into the extracellular medium. Cell impermeable LgBiT and Furimazine substrate (Fz) are added as components of the Bio-Glo-NB TCK Reagent. HiBiT complementation with LgBiT generates NanoBiT® luciferase, a bright, luminescent enzyme.